Scott Henry
Stock Analyst at Alliance Global Partners
(1.37)
# 3,569
Out of 5,031 analysts
51
Total ratings
43.4%
Success rate
-3.39%
Average return
Main Sectors:
Stocks Rated by Scott Henry
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TNON Tenon Medical | Initiates: Buy | $3 | $1.24 | +141.94% | 1 | Apr 9, 2025 | |
| QSI Quantum-Si incorporated | Initiates: Buy | $3.75 | $2.28 | +64.47% | 1 | Feb 7, 2025 | |
| VVOS Vivos Therapeutics | Maintains: Buy | $8.25 → $6 | $2.90 | +106.90% | 4 | Nov 19, 2024 | |
| LPCN Lipocine | Initiates: Buy | $10 | $3.02 | +231.13% | 1 | Sep 24, 2024 | |
| ASRT Assertio Holdings | Initiates: Buy | $2.75 | $0.80 | +243.66% | 1 | May 28, 2024 | |
| DERM Journey Medical | Initiates: Buy | $8.5 | $7.17 | +18.55% | 2 | Feb 16, 2024 | |
| RNXT RenovoRx | Initiates: Buy | $4 | $1.12 | +257.14% | 3 | Feb 2, 2024 | |
| FBIO Fortress Biotech | Maintains: Buy | $30 → $15 | $2.70 | +455.56% | 2 | Nov 29, 2023 | |
| RVPH Reviva Pharmaceuticals Holdings | Reiterates: Buy | $12 | $0.57 | +1,988.41% | 2 | Oct 30, 2023 | |
| CSBR Champions Oncology | Maintains: Buy | $9 → $7.5 | $6.44 | +16.46% | 2 | Sep 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $13 | $11.97 | +8.60% | 4 | Aug 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $19 → $24 | $33.54 | -28.43% | 2 | May 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $10 → $16 | $20.55 | -24.57% | 2 | Aug 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $55 → $58 | $86.63 | -33.05% | 6 | Aug 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $32 → $36 | $73.43 | -50.97% | 1 | Aug 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $11 | $1.04 | +957.69% | 3 | May 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $4 → $6 | $3.19 | +88.09% | 2 | Feb 26, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $6,000 → $5,750 | $2.10 | +273,709.52% | 1 | Feb 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.90 | - | 1 | Dec 4, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $7 | $1.03 | +579.61% | 3 | Nov 11, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $18.62 | - | 5 | Apr 18, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.04 | - | 2 | Mar 26, 2018 |
Tenon Medical
Apr 9, 2025
Initiates: Buy
Price Target: $3
Current: $1.24
Upside: +141.94%
Quantum-Si incorporated
Feb 7, 2025
Initiates: Buy
Price Target: $3.75
Current: $2.28
Upside: +64.47%
Vivos Therapeutics
Nov 19, 2024
Maintains: Buy
Price Target: $8.25 → $6
Current: $2.90
Upside: +106.90%
Lipocine
Sep 24, 2024
Initiates: Buy
Price Target: $10
Current: $3.02
Upside: +231.13%
Assertio Holdings
May 28, 2024
Initiates: Buy
Price Target: $2.75
Current: $0.80
Upside: +243.66%
Journey Medical
Feb 16, 2024
Initiates: Buy
Price Target: $8.5
Current: $7.17
Upside: +18.55%
RenovoRx
Feb 2, 2024
Initiates: Buy
Price Target: $4
Current: $1.12
Upside: +257.14%
Fortress Biotech
Nov 29, 2023
Maintains: Buy
Price Target: $30 → $15
Current: $2.70
Upside: +455.56%
Reviva Pharmaceuticals Holdings
Oct 30, 2023
Reiterates: Buy
Price Target: $12
Current: $0.57
Upside: +1,988.41%
Champions Oncology
Sep 22, 2023
Maintains: Buy
Price Target: $9 → $7.5
Current: $6.44
Upside: +16.46%
Aug 16, 2023
Maintains: Buy
Price Target: $10 → $13
Current: $11.97
Upside: +8.60%
May 3, 2023
Maintains: Buy
Price Target: $19 → $24
Current: $33.54
Upside: -28.43%
Aug 24, 2022
Downgrades: Neutral
Price Target: $10 → $16
Current: $20.55
Upside: -24.57%
Aug 3, 2021
Maintains: Neutral
Price Target: $55 → $58
Current: $86.63
Upside: -33.05%
Aug 2, 2021
Maintains: Buy
Price Target: $32 → $36
Current: $73.43
Upside: -50.97%
May 12, 2021
Maintains: Buy
Price Target: $9 → $11
Current: $1.04
Upside: +957.69%
Feb 26, 2021
Maintains: Buy
Price Target: $4 → $6
Current: $3.19
Upside: +88.09%
Feb 16, 2021
Maintains: Buy
Price Target: $6,000 → $5,750
Current: $2.10
Upside: +273,709.52%
Dec 4, 2020
Downgrades: Neutral
Price Target: n/a
Current: $1.90
Upside: -
Nov 11, 2020
Upgrades: Buy
Price Target: $7
Current: $1.03
Upside: +579.61%
Apr 18, 2019
Upgrades: Buy
Price Target: n/a
Current: $18.62
Upside: -
Mar 26, 2018
Downgrades: Neutral
Price Target: n/a
Current: $1.04
Upside: -